ID: ALA4277509

Max Phase: Preclinical

Molecular Formula: C21H30O4

Molecular Weight: 346.47

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC(=O)[C@@]1(C)CCC[C@]2(C)c3c(O)c(O)cc(C(C)C)c3CC[C@@H]12

Standard InChI:  InChI=1S/C21H30O4/c1-12(2)14-11-15(22)18(23)17-13(14)7-8-16-20(17,3)9-6-10-21(16,4)19(24)25-5/h11-12,16,22-23H,6-10H2,1-5H3/t16-,20+,21+/m1/s1

Standard InChI Key:  NPNOFWVCLCUXQM-CZAAIQMYSA-N

Associated Targets(Human)

A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
T84 (240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PBMC (10003 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 346.47Molecular Weight (Monoisotopic): 346.2144AlogP: 4.40#Rotatable Bonds: 2
Polar Surface Area: 66.76Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.56CX Basic pKa: CX LogP: 5.29CX LogD: 5.28
Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.61Np Likeness Score: 2.11

References

1. Mahdjour S, Guardia JJ, Rodríguez-Serrano F, Garrido JM, López-Barajas IB, Mut-Salud N, Chahboun R, Alvarez-Manzaneda E..  (2018)  Synthesis and antiproliferative activity of podocarpane and totarane derivatives.,  158  [PMID:30248657] [10.1016/j.ejmech.2018.09.051]

Source